United Capital Financial Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

United Capital Financial Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,488	Closed	-$423K	–	1236
2021 Q1	$423K	Sell	5,488 -9,765	-64%	-$900K	﹤0.01%	893
2020 Q4	$1.51M	Sell	15,253 -6,874	-31%	-$841K	0.01%	568
2020 Q3	$3.14M	Sell	22,127 -4,759	-18%	-$793K	0.02%	419
2020 Q2	$5.3M	Sell	26,886 -469	-2%	-$97.1K	0.04%	346
2020 Q1	$5.36M	Buy	+27,355	New	+$5.89M	0.04%	323

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

United Capital Financial Advisors's LKFT Position: Q2 2021 in Review

United Capital Financial Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 5,488 shares — an estimated $423K sold.

United Capital Financial Advisors first reported a position in LKFT in Q1 2020 and held it in 5 quarters. The position peaked at $5.36M in Q1 2020. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

United Capital Financial Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
United Capital Financial Advisors sold 5,488 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $423K.
United Capital Financial Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 5 quarters.
United Capital Financial Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.36M in Q1 2020.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on United Capital Financial Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.